Robaxin 750 tablets

Ország: Egyesült Királyság

Nyelv: angol

Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktív összetevők:

Methocarbamol

Beszerezhető a:

Almirall Ltd

ATC-kód:

M03BA03

INN (nemzetközi neve):

Methocarbamol

Adagolás:

750mg

Gyógyszerészeti forma:

Oral tablet

Az alkalmazás módja:

Oral

Osztály:

No Controlled Drug Status

Recept típusa:

Valid as a prescribable product

Termék összefoglaló:

BNF: 10020200; GTIN: 5022690000127

Betegtájékoztató

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ROBAXIN
®-
750
750 MG FILM-COATED TABLETS FOR ORAL USE
Methocarbamol
100 Tablets
Dosage: 2 tablets to be swallowed 4 times a day
or as directed by your doctor.
Please read the enclosed leaflet
Each tablet contains methocarbamol 750mg.
Also contains: maize starch, sodium lauryl sulphate,
hypromellose and propylene glycol.
Keep out of the sight and reach of children
Warning: May cause drowsiness.
If affected, do not drive or operate machinery.
Avoid alcoholic drink.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may
harm them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Robaxin-750 is and what it is used for
2.
What you need to know before you take Robaxin-750
3.
How to take Robaxin-750
4.
Possible side effects
5.
How to store Robaxin-750
6.
Contents of the pack and other information
1.
WHAT ROBAXIN-750 IS AND WHAT IT IS USED FOR
Robaxin-750 contains the active ingredient methocarbamol (750mg) which
belongs to a group
of medicines called muscle relaxants.
Robaxin-750 is used for the short-term treatment of pain and muscle
spasm caused by injuries
such as sprains and strains.
2.
WHAT YOU NEED TO KNOW BEFORE YOUR TAKE ROBAXIN-750
DO NOT TAKE ROBAXIN-750 IF YOU:
•
are allergic to methocarbamol, or have had any problems in the past
with medicines
containing methocarbamol
•
are allergic to any of the other ingredients of this medicine (listed
in section 6)
•
have ever suffered any brain damage or coma
•
suffer from epilepsy or convulsions
•
suffer from muscle weakness (a disease called myasthenia gravis)

Termékjellemzők

OBJECT 1
ROBAXIN-750
Summary of Product Characteristics Updated 08-Aug-2017 | Almirall
Limited
1. Name of the medicinal product
Robaxin-750, 750 mg film-coated tablets
2. Qualitative and quantitative composition
Each white, capsule-shaped tablet contains 750 mg methocarbamol.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet.
4. Clinical particulars
4.1 Therapeutic indications
As a short-term adjunct to the symptomatic treatment of acute
musculoskeletal disorders associated with
painful muscle spasms.
4.2 Posology and method of administration
For oral use.
Posology
Adults: The usual dose is 2 tablets four times daily but therapeutic
response has been achieved with doses
as low as 1 tablet three times daily.
Elderly: Half the maximum dose or less may be sufficient to produce a
therapeutic response.
_Paediatric population_
Not recommended.
_Hepatically impaired_
In patients with chronic hepatic disease the elimination half-life may
be prolonged. Therefore,
consideration should be given to increasing the dose interval.
4.3 Contraindications
Hypersensitivity to methocarbamol or to any of the excipients listed
in section 6.1. Coma or pre-coma
states. Known brain damage or epilepsy. Myasthenia gravis.
4.4 Special warnings and precautions for use
Robaxin-750 should be used with caution in patients with renal and
hepatic insufficiency.
4.5 Interaction with other medicinal products and other forms of
interaction
This product may potentiate the effects of other central nervous
system depressants and stimulants
including alcohol, barbiturates, anaesthetics and appetite
suppressants. The effects of anticholinergics,
e.g. atropine and some psychotropic drugs, may be potentiated by
methocarbamol. Methocarbamol may
inhibit the effect of pyridostigmine bromide. Therefore methocarbamol
should be used with caution in
patients with myasthenia gravis receiving anticholinesterase agents.
Little is known about the possibility
of interactions with other drugs.
Methocarbamol may cause colour int